Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don C Yoo

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Radiology|August 14, 2019
U.S. PET/CT and Gamma Camera Diagnostic Reference Levels and Achievable Administered Activities for Noncardiac Nuclear Medicine StudiesMurray D Becker, Priscilla F Butler, Mazen Siam, et al.
Academic Radiology|November 25, 2019
The Current State of Nuclear Medicine and Nuclear Radiology: Workforce Trends, Training Pathways, and Training Program WebsitesJack H Ruddell, Adam E M Eltorai, Oliver Y Tang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 28, 2017
Brain amyloid in preclinical Alzheimer's disease is associated with increased driving riskBrian R Ott, Richard N Jones, Richard B Noto, et al.
Journal of the American College of Radiology : JACR|May 17, 2019
Training and Education Requirements for Authorized Users of Therapeutic Radiopharmaceuticals: Changes Under Consideration for 10CFR35.390 and Their Potential ImpactPaul E Wallner, Ralph P Lieto, Gary L Dillehay, et al.
Neurobiology of Aging|August 3, 2015
Disruption of cholinergic neurotransmission exacerbates Aβ-related cognitive impairment in preclinical Alzheimer's diseaseYen Ying Lim, Paul Maruff, Rachel Schindler, et al.
Journal of the American College of Radiology : JACR|August 30, 2020
Potential Significant Changes in Nuclear Regulatory Commission Policies Regarding Training and Experience Requirements for the Use of RadiopharmaceuticalsPaul E Wallner, Ralph P Lieto, Gary L Dillehay, et al.
AJR. American Journal of Roentgenology|April 22, 2016
Acute Lower Gastrointestinal Bleeding: Temporal Factors Associated With Positive Findings on Catheter Angiography After (99m)Tc-Labeled RBC ScanningMaggie Chung, Gregory J Dubel, Richard B Noto, et al.
AJR. American Journal of Roentgenology|February 8, 2023
Imaging of Small-Bowel Neuroendocrine Neoplasms: <i>AJR</i> Expert Panel Narrative ReviewPatrick J Navin, Eric C Ehman, Jason B Liu, et al.
Alzheimer'S Research & Therapy|March 27, 2020
Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aβ-related cognitive impairment in preclinical Alzheimer's disease after a 27-month delay intervalJessica Alber, Paul Maruff, Cláudia Y Santos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 25, 2023
A VISION Substudy of Reader Agreement on <sup>68</sup>Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for <sup>177</sup>Lu-PSMA-617 Radioligand TherapyPhillip H Kuo, Don C Yoo, Ryan Avery, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Radiology|August 14, 2019
U.S. PET/CT and Gamma Camera Diagnostic Reference Levels and Achievable Administered Activities for Noncardiac Nuclear Medicine StudiesMurray D Becker, Priscilla F Butler, Mazen Siam, et al.
Academic Radiology|November 25, 2019
The Current State of Nuclear Medicine and Nuclear Radiology: Workforce Trends, Training Pathways, and Training Program WebsitesJack H Ruddell, Adam E M Eltorai, Oliver Y Tang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 28, 2017
Brain amyloid in preclinical Alzheimer's disease is associated with increased driving riskBrian R Ott, Richard N Jones, Richard B Noto, et al.
Journal of the American College of Radiology : JACR|May 17, 2019
Training and Education Requirements for Authorized Users of Therapeutic Radiopharmaceuticals: Changes Under Consideration for 10CFR35.390 and Their Potential ImpactPaul E Wallner, Ralph P Lieto, Gary L Dillehay, et al.
Neurobiology of Aging|August 3, 2015
Disruption of cholinergic neurotransmission exacerbates Aβ-related cognitive impairment in preclinical Alzheimer's diseaseYen Ying Lim, Paul Maruff, Rachel Schindler, et al.
Journal of the American College of Radiology : JACR|August 30, 2020
Potential Significant Changes in Nuclear Regulatory Commission Policies Regarding Training and Experience Requirements for the Use of RadiopharmaceuticalsPaul E Wallner, Ralph P Lieto, Gary L Dillehay, et al.
AJR. American Journal of Roentgenology|April 22, 2016
Acute Lower Gastrointestinal Bleeding: Temporal Factors Associated With Positive Findings on Catheter Angiography After (99m)Tc-Labeled RBC ScanningMaggie Chung, Gregory J Dubel, Richard B Noto, et al.
AJR. American Journal of Roentgenology|February 8, 2023
Imaging of Small-Bowel Neuroendocrine Neoplasms: <i>AJR</i> Expert Panel Narrative ReviewPatrick J Navin, Eric C Ehman, Jason B Liu, et al.
Alzheimer'S Research & Therapy|March 27, 2020
Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aβ-related cognitive impairment in preclinical Alzheimer's disease after a 27-month delay intervalJessica Alber, Paul Maruff, Cláudia Y Santos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 25, 2023
A VISION Substudy of Reader Agreement on <sup>68</sup>Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for <sup>177</sup>Lu-PSMA-617 Radioligand TherapyPhillip H Kuo, Don C Yoo, Ryan Avery, et al.
Pageof 4